Works matching IS 02704137 AND DT 2018 AND VI 78 AND IP 14

Results: 10

Development of an orthotopic canine prostate cancer model expressing human GRPr.

Published in:

Prostate, 2018, v. 78, n. 14, p. 1111, doi. 10.1002/pros.23686

By:

Tweedle, Michael F.;
Ding, Haiming;
Drost, William T.;
Dowell, Joshua;
Spain, James;
Joseph, Mathew;
Elshafae, Said M.;
Menendez, Maria‐Isabela;
Gong, Li;
Kothandaraman, Shankaran;
Dirksen, Wessel P.;
Wright, Chadwick L.;
Bahnson, Robert;
Knopp, Michael V.;
Rosol, Thomas J.

Publication type:

Article

Ga‐68‐PSMA PET/CT in treatment‐naïve patients with prostate cancer: Which clinical parameters and risk stratification systems best predict PSMA‐positive metastases?

Published in:

Prostate, 2018, v. 78, n. 14, p. 1103, doi. 10.1002/pros.23685

By:

Rogasch, Julian M.;
Cash, Hannes;
Zschaeck, Sebastian;
Elezkurtaj, Sefer;
Brenner, Winfried;
Hamm, Bernd;
Makowski, Marcus;
Amthauer, Holger;
Furth, Christian;
Baur, Alexander D. J.

Publication type:

Article

Identification and preliminary study of immunogens involved in autoimmune prostatitis in human males.

Published in:

Prostate, 2018, v. 78, n. 14, p. 1092, doi. 10.1002/pros.23684

By:

Lu, Jin‐Chun;
Shen, Jia‐Ming;
Hu, Xue‐Chun;
Peng, Long‐Ping;
Hong, Zhi‐Wei;
Yao, Bing

Publication type:

Article

A five‐CpG DNA methylation score to predict metastatic‐lethal outcomes in men treated with radical prostatectomy for localized prostate cancer.

Published in:

Prostate, 2018, v. 78, n. 14, p. 1084, doi. 10.1002/pros.23667

By:

Zhao, Shanshan;
Leonardson, Amy;
Geybels, Milan S.;
McDaniel, Andrew S.;
Yu, Ming;
Kolb, Suzanne;
Zong, Hong;
Carter, Kelly;
Siddiqui, Javed;
Cheng, Anqi;
Wright, Jonathan L.;
Pritchard, Colin C.;
Lance, Raymond;
Troyer, Dean;
Fan, Jian‐Bing;
Ostrander, Elaine A.;
Dai, James Y.;
Tomlins, Scott A.;
Feng, Ziding;
Stanford, Janet L.

Publication type:

Article

Undetectable prostate‐specific antigen after short‐course androgen deprivation therapy for biochemically recurrent patients correlates with metastasis‐free survival and prostate cancer‐specific survival.

Published in:

Prostate, 2018, v. 78, n. 14, p. 1077, doi. 10.1002/pros.23666

By:

Lim, Daniel M.;
Gulati, Roman;
Aleshin‐Guendel, Serge;
Gawne, Agnes;
Wingate, Jonathan T.;
Cheng, Heather H.;
Etzioni, Ruth;
Yu, Evan Y.

Publication type:

Article

Mathematical modeling of intracrine androgen metabolism in prostate cancer: Methodological aspects.

Published in:

Prostate, 2018, v. 78, n. 14, p. 1069, doi. 10.1002/pros.23665

By:

Cook, Sarah F.;
Fiandalo, Michael V.;
Watt, David S.;
Wu, Yue;
Mohler, James L.;
Bies, Robert R.

Publication type:

Article

Differences in inherited risk among relatives of hereditary prostate cancer patients using genetic risk score.

Published in:

Prostate, 2018, v. 78, n. 14, p. 1063, doi. 10.1002/pros.23664

By:

Helfand, Brian T.;
Chen, Haitao;
Fantus, Richard J.;
Conran, Carly A.;
Brendler, Charles B.;
Zheng, Siquan Lilly;
Walsh, Patrick C.;
Isaacs, William B.;
Xu, Jianfeng

Publication type:

Article

A dose finding clinical trial of cabozantinib (XL184) administered in combination with abiraterone acetate in metastatic castration‐resistant prostate cancer.

Published in:

Prostate, 2018, v. 78, n. 14, p. 1053, doi. 10.1002/pros.23662

By:

Choudhury, Atish D.;
Gray, Kathryn P.;
Supko, Jeffrey G.;
Harshman, Lauren C.;
Taplin, Mary‐Ellen;
Pace, Amanda F.;
Farina, Matthew;
Zukotynski, Katherine A.;
Bernard, Brandon;
Kantoff, Philip W.;
Pomerantz, Mark;
Sweeney, Christopher

Publication type:

Article

Mineralocorticoid receptor signaling affects therapeutic effect of enzalutamide.

Published in:

Prostate, 2018, v. 78, n. 14, p. 1045, doi. 10.1002/pros.23661

By:

Shiota, Masaki;
Fujimoto, Naohiro;
Higashijima, Katuyoshi;
Imada, Kenjiro;
Kashiwagi, Eiji;
Takeuchi, Ario;
Inokuchi, Junichi;
Tatsugami, Katsunori;
Kajioka, Shunichi;
Uchiumi, Takeshi;
Eto, Masatoshi

Publication type:

Article

Issue Information ‐ Editorial Board.

Published in:: Prostate, 2018, v. 78, n. 14, p. 1044, doi. 10.1002/pros.23530
Publication type:: Article